Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00426283 · ClinicalTrials.gov registry record · Phase 2

A Study of Flovent in Patients With Eosinophilic Esophagitis

A Phase 2 study of Eosinophilic Esophagitis, sponsored by Marc Rothenberg, MD.

Completed
Registry status
Phase 2
Development phase
42
Enrollment target
4
Study locations

NCT00426283 is a Phase 2 study of Eosinophilic Esophagitis that has completed, run by Marc Rothenberg, MD. The registered enrollment target is 42 participants, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00426283, a Phase 2 study of Eosinophilic Esophagitis, has completed, sponsored by Marc Rothenberg, MD.

COMPLETED
Registry status
Phase 2
Development phase
42 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to test the effects (both good and bad) of high dose swallowed fluticasone propionate (Flovent) in subjects with eosinophilic esophagitis (EoE).

Conditions Studied

Eosinophilic Esophagitis

Interventions

  • OTHER Placebo
  • DRUG Flovent

Study Locations (4)

Colorado

  • The Children's Hospital of Denver - Aurora

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2007-01
Est. Completion 2012-03
Phase Phase 2

Sponsor

Marc Rothenberg, MD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00426283

The ClinicalTrials.gov registry entry for NCT00426283 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (95% lower). The listed sponsor is Marc Rothenberg, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00426283 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Colorado, Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00426283 about?

NCT00426283 is a clinical study titled "A Study of Flovent in Patients With Eosinophilic Esophagitis". The purpose of this study is to test the effects (both good and bad) of high dose swallowed fluticasone propionate (Flovent) in subjects with eosinophilic esophagitis (EoE).

What is the current status of trial NCT00426283?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2007-01. Estimated completion is 2012-03.

What conditions does trial NCT00426283 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis.

What interventions are being tested in trial NCT00426283?

The interventions under investigation include: Placebo (OTHER), Flovent (DRUG).

Who is sponsoring clinical trial NCT00426283?

This trial is sponsored by Marc Rothenberg, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00426283 being conducted?

This trial has 4 study locations across Colorado, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Eosinophilic Esophagitis

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.